Stock PRLD PRELUDE THERAPEUTICS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Prelude Therapeutics Incorporated

Equities

PRLD

US74065P1012

Real-time Estimate Cboe BZX
Other stock markets
 03:44:24 2024-07-09 pm EDT 		5-day change 1st Jan Change
3.465 USD +0.43% Intraday chart for Prelude Therapeutics Incorporated -5.63% -17.56%
02:35pm Prelude Therapeutics Inks Deal With Merck for Phase 2 Study to Evaluate its SMARCA2 Degrader With Keytruda MT
01:30pm Prelude Therapeutics Announces Clinical Collaboration with Merck to Evaluate PRT3789 in Combination with KEYTRUDA® (pembrolizumab) in Patients with SMARCA4-Mutated Cancers CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. PRLD Stock
  4. News Prelude Therapeutics Incorporated
  5. Official Publications